SMSPHARMA Q1 FY27 results at a glance
SMS PHARMACEUTICALS LTD. Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹207 cr |
|---|
| Revenue YoY | +5.6% |
|---|
| Operating profit | ₹30.96 cr |
|---|
| Operating margin | 15.0% |
|---|
| Net profit | ₹20.91 cr |
|---|
| Net profit YoY | +2.0% |
|---|
| Net profit QoQ | -36.1% |
|---|
| Net margin | 10.1% |
|---|
| Basic EPS | ₹2.23 |
|---|
| TTM revenue | ₹898 cr |
|---|
| TTM net profit | ₹102 cr |
|---|
| TTM net margin | 11.4% |
|---|
SMSPHARMA Q1 FY27 results: what the numbers say
SMS PHARMACEUTICALS LTD. (SMSPHARMA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹207 cr and a net profit of ₹20.91 cr, translating into earnings per share of ₹2.23.
Compared with the same quarter a year earlier, revenue grew by +5.6% and net profit grew marginally by +2.0%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹30.96 cr, an operating margin of 15.0% versus 14.4% a year ago — a gain of 0.6 percentage points.
SMSPHARMA quarter-wise results table
Net profit
₹20.91 cr
+2.0% YoY
Operating profit
₹30.96 cr
+9.6% YoY
SMS PHARMACEUTICALS LTD. (SMSPHARMA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹207 cr | ₹30.96 cr | ₹20.91 cr | 15.0% | 10.1% | ₹2.23 | +2.0% | -36.1% |
| Q4 FY262026-03-31 | ₹238 cr | ₹29.77 cr | ₹32.71 cr | 12.5% | 13.7% | ₹3.58 | — | +39.4% |
| Q3 FY262025-12-31 | ₹210 cr | ₹33.63 cr | ₹23.47 cr | 16.0% | 11.2% | ₹2.59 | — | -7.3% |
| Q2 FY262025-09-30 | ₹242 cr | ₹38.34 cr | ₹25.31 cr | 15.8% | 10.4% | ₹2.84 | — | +23.5% |
| Q1 FY262025-06-30 | ₹196 cr | ₹28.24 cr | ₹20.49 cr | 14.4% | 10.5% | ₹2.31 | — | — |
| TTM (last 4 quarters) | ₹898 cr | ₹133 cr | ₹102 cr | 14.8% | 11.4% | ₹11.24 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
SMSPHARMA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
SMS PHARMACEUTICALS LTD. quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹207 cr | ₹238 cr | ₹210 cr | ₹242 cr | ₹196 cr |
|---|
| Total expenses | ₹176 cr | ₹208 cr | ₹177 cr | ₹204 cr | ₹168 cr |
|---|
| Gross profit | ₹74.93 cr | ₹81.28 cr | ₹74.89 cr | ₹76.87 cr | ₹65.35 cr |
|---|
| Operating profit (EBIT) | ₹30.96 cr | ₹29.77 cr | ₹33.63 cr | ₹38.34 cr | ₹28.24 cr |
|---|
| Operating margin | 15.0% | 12.5% | 16.0% | 15.8% | 14.4% |
|---|
| Interest cost | ₹5.5 cr | ₹5.28 cr | ₹6.22 cr | ₹5.74 cr | ₹5.84 cr |
|---|
| Profit before tax | ₹27.21 cr | ₹27.07 cr | ₹31.16 cr | ₹34.04 cr | ₹24.37 cr |
|---|
| Tax expense | ₹7 cr | ₹6.1 cr | ₹7.97 cr | ₹8.91 cr | ₹5.65 cr |
|---|
| Effective tax rate | 25.7% | 22.5% | 25.6% | 26.2% | 23.2% |
|---|
| Net profit (PAT) | ₹20.91 cr | ₹32.71 cr | ₹23.47 cr | ₹25.31 cr | ₹20.49 cr |
|---|
| Net profit margin | 10.1% | 13.7% | 11.2% | 10.4% | 10.5% |
|---|
| Basic EPS | ₹2.23 | ₹3.58 | ₹2.59 | ₹2.84 | ₹2.31 |
|---|
| Diluted EPS | ₹2.23 | ₹3.58 | ₹2.59 | ₹2.84 | ₹2.31 |
|---|
SMSPHARMA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +5.6% | — | — | — | — |
|---|
| Revenue QoQ | -13.0% | +13.1% | -13.2% | +23.7% | — |
|---|
| Operating profit YoY | +9.6% | — | — | — | — |
|---|
| Operating profit QoQ | +4.0% | -11.5% | -12.3% | +35.8% | — |
|---|
| Net profit YoY | +2.0% | — | — | — | — |
|---|
| Net profit QoQ | -36.1% | +39.4% | -7.3% | +23.5% | — |
|---|
| EPS YoY | -3.5% | — | — | — | — |
|---|
| EPS QoQ | -37.7% | +38.2% | -8.8% | +22.9% | — |
|---|
SMSPHARMA annual results history
Full-year performance for SMS PHARMACEUTICALS LTD., useful for reading each quarter in context.
SMS PHARMACEUTICALS LTD. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹883 cr | ₹779 cr | ₹706 cr | ₹520 cr |
|---|
| Total expenses | ₹750 cr | ₹675 cr | ₹621 cr | ₹497 cr |
|---|
| Gross profit | ₹299 cr | ₹261 cr | ₹209 cr | ₹129 cr |
|---|
| Operating profit (EBIT) | ₹133 cr | ₹105 cr | ₹85.25 cr | ₹22.48 cr |
|---|
| Operating margin | 15.1% | 13.4% | 12.1% | 4.3% |
|---|
| Interest cost | ₹22.12 cr | ₹17.43 cr | ₹22.62 cr | ₹20.99 cr |
|---|
| Profit before tax | ₹117 cr | ₹92.34 cr | ₹66.11 cr | ₹5.35 cr |
|---|
| Tax expense | ₹28.64 cr | ₹24.94 cr | ₹16.91 cr | ₹1.47 cr |
|---|
| Effective tax rate | 24.6% | 27.0% | 25.6% | 27.4% |
|---|
| Net profit (PAT) | ₹102 cr | ₹69.14 cr | ₹49.83 cr | -₹7.06 cr |
|---|
| Net profit margin | 11.5% | 8.9% | 7.1% | -1.4% |
|---|
| Basic EPS | ₹11.15 | ₹8.16 | ₹5.89 | ₹-0.83 |
|---|
| Diluted EPS | ₹11.15 | ₹8.16 | ₹5.89 | ₹-0.83 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹207 cr against ₹196 cr in Q1 FY26, and ₹238 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -13.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹176 cr, or 85.0% of revenue, with operating profit grew +9.6% year on year.
Margins, tax and profitability
Net profit of ₹20.91 cr works out to a net margin of 10.1% compared with 10.5% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, SMS PHARMACEUTICALS LTD. reported profit before tax of ₹27.21 cr, a tax charge of ₹7 cr (effective rate 25.7%), interest cost of ₹5.5 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹32.71 cr in Q4 FY26 to ₹20.91 cr in Q1 FY27, a change of -36.1%.
Trailing twelve months and annual context
Across the trailing four quarters SMS PHARMACEUTICALS LTD. has generated revenue of ₹898 cr and net profit of ₹102 cr, a trailing net margin of 11.4%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹883 cr with net profit of ₹102 cr and EPS of ₹11.15, versus the prior year where revenue grew +13.3% and profit grew +47.5%.
What to watch in the next SMSPHARMA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
SMS PHARMACEUTICALS LTD. has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
SMSPHARMA results coverage
No results report published for SMSPHARMA yet — our desk covers each quarter within minutes of the filing.
SMSPHARMA quarterly results FAQs
What were SMS PHARMACEUTICALS LTD. (SMSPHARMA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), SMS PHARMACEUTICALS LTD. reported revenue of ₹207 cr and net profit of ₹20.91 cr, a change of +2.0% year on year on +5.6% revenue growth. EPS stood at ₹2.23.
What is SMSPHARMA profit margin in Q1 FY27?
SMS PHARMACEUTICALS LTD. posted a net profit margin of 10.1% and an operating margin of 15.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹898 cr and net profit ₹102 cr.
Did SMSPHARMA results beat the previous quarter?
SMS PHARMACEUTICALS LTD. net profit changed -36.1% quarter on quarter, from ₹32.71 cr in Q4 FY26 to ₹20.91 cr in Q1 FY27.
When are SMS PHARMACEUTICALS LTD. (SMSPHARMA) quarterly results?
SMS PHARMACEUTICALS LTD. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see SMSPHARMA latest quarterly results?
Results coverage for SMSPHARMA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the SMSPHARMA stock page.
What is SMS PHARMACEUTICALS LTD. annual revenue and profit?
For FY26, SMS PHARMACEUTICALS LTD. reported full-year revenue of ₹883 cr and net profit of ₹102 cr, with EPS of ₹11.15.
How many quarterly results has SMSPHARMA declared recently?
Past results dates for SMSPHARMA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
